Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital
- PMID: 19580887
- DOI: 10.1016/j.cct.2009.06.009
Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital
Abstract
Introduction: Most research on the barriers to recruitment of ethnic and racial minorities focuses on patient factors. The purpose of this exploratory case study was to examine how institutional factors impacted recruitment and enrollment in a public hospital clinic frequented by minority patients.
Methods: We used ethnographic methods (observations of patient-provider interactions and semi-structured interviews) to document and explain how a number of institutional barriers hindered trials enrollment in a public hospital outpatient breast cancer clinic.
Results: We identified two categories of institutional barriers: (1) organizational climate, and (2) research specific resources. Organizational climate included qualities of the clinic and hospital such as the clinic structure (clinic hours, patient assignment method), the interdisciplinary care team, the lack of continuity of care, and competing provider priorities of clinical care, teaching, and research. Research specific resources included: staff, funds and institutional status to facilitate opening a range of trials; and linguistically and literacy-appropriate research resources.
Conclusion: Although we cannot determine from our qualitative data the relative impact of different kinds of barriers (e.g. patient, provider, institutional barriers), our data highlights the need to address the role of institutional barriers in efforts to improve minority recruitment to clinical trials. Recruiting participants in safety-net settings may be a reasonable strategy for increasing accrual of ethnic and racial minority patients to cancer clinical trials. However, our qualitative data suggest that while opening protocols for accrual at minority-serving institutions may signal nominal access to trials, achieving substantive access may require further steps to overcome substantial institutional barriers.
Similar articles
-
HIV/AIDS: a minority health issue.Med Clin North Am. 2005 Jul;89(4):895-912. doi: 10.1016/j.mcna.2005.03.005. Med Clin North Am. 2005. PMID: 15925655 Review.
-
Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'.Cancer. 2009 Feb 1;115(3):608-15. doi: 10.1002/cncr.24028. Cancer. 2009. PMID: 19127544
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.Am J Surg. 2012 Apr;203(4):415-22. doi: 10.1016/j.amjsurg.2011.02.005. Epub 2011 Oct 13. Am J Surg. 2012. PMID: 21996347
-
Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.J Clin Oncol. 2006 May 10;24(14):2209-15. doi: 10.1200/JCO.2005.04.8116. J Clin Oncol. 2006. PMID: 16682741 Review.
Cited by
-
Recruitment of black subjects for a natural history study of intracerebral hemorrhage.J Health Care Poor Underserved. 2013 Feb;24(1):27-35. doi: 10.1353/hpu.2013.0007. J Health Care Poor Underserved. 2013. PMID: 23377714 Free PMC article.
-
Barriers for cancer clinical trial enrollment: A qualitative study of the perspectives of healthcare providers.Contemp Clin Trials Commun. 2022 May 28;28:100939. doi: 10.1016/j.conctc.2022.100939. eCollection 2022 Aug. Contemp Clin Trials Commun. 2022. PMID: 35707483 Free PMC article.
-
Lupus community panel proposals for optimising clinical trials: 2018.Lupus Sci Med. 2018 Mar 23;5(1):e000258. doi: 10.1136/lupus-2018-000258. eCollection 2018. Lupus Sci Med. 2018. PMID: 29657738 Free PMC article. Review.
-
Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT).Breast Cancer Res Treat. 2019 Aug;177(1):93-101. doi: 10.1007/s10549-019-05274-0. Epub 2019 May 24. Breast Cancer Res Treat. 2019. PMID: 31127468 Review.
-
African American men's and women's perceptions of clinical trials research: focusing on prostate cancer among a high-risk population in the South.J Health Care Poor Underserved. 2013 Nov;24(4):1784-800. doi: 10.1353/hpu.2013.0187. J Health Care Poor Underserved. 2013. PMID: 24185170 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical